Serveur d'exploration Chloroquine - Exploration (Accueil)

Index « Teeft.i » - entrée « Doxorubicin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Doxazosin < Doxorubicin < Doxorubicin efficacy  Facettes :

List of bibliographic references indexed by Doxorubicin

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
001684 (2010) Joo H. Lee [Corée du Sud] ; Si H. Yang [Corée du Sud] ; Jung M. Oh [Corée du Sud] ; Myung G. Lee [Corée du Sud]Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus
001B35 (2007) Allyn M. Kaufmann [États-Unis] ; Jeffrey P. Krise [États-Unis]Lysosomal sequestration of amine‐containing drugs: Analysis and therapeutic implications
002401 (2001) Ian F. Tannock [Canada]Collaborative clinical trials: quality or quantity?
002490 (2000) Marko Vezmar [Canada] ; Elias Georges [Canada]Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs
002633 (1999) P. B. Jensen [Danemark] ; M. Sehested [Danemark] ; S. W. Langer [Danemark] ; H. H. Hansen [Danemark]Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory
002773 (1998) Toshiwo Andoh [Japon] ; Ryoji Ishida [Japon]Catalytic inhibitors of DNA topoisomerase II
002779 (1998) Patrick G. Bray [Royaume-Uni] ; Stephen A. Ward [Royaume-Uni]A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum
002818 (1998) Index
002884 (1997) D. J. A Crommelin [Pays-Bas] ; T. Daemen [Pays-Bas] ; G. L Scherphof [Pays-Bas] ; M. H Vingerhoeds [Pays-Bas] ; J. L. M Heeremans [Pays-Bas] ; C. Kluft [Pays-Bas] ; G. Storm [Pays-Bas]Liposomes: vehicles for the targeted and controlled delivery of peptides and proteins
002904 (1997) Marcin Kolaczkowski [Belgique] ; André Goffeau [Belgique]Active efflux by multidrug transporters as one of the strategies to evade chemotherapy and novel practical implications of yeast pleiotropic drug resistance
002B50 (1995) James F. Eliason [Japon] ; Henri Ramuz [Suisse] ; Takashi Yoshikubo [Japon] ; Tohru Ishikawa [Japon] ; Taeko Yamamoto [Japon] ; Takashi Tsuruo [Japon]Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro
002D80 (1993) James M. Croop [États-Unis]P-glycoprotein structure and evolutionary homologies
002E46 (1992) Volume 1992, No. 14 July 31, 1992
002F08 (1991) Subject index for volume 41, 1991
002F70 (1991) Roger Henriksson [Suède] ; Khama O. Rogo [Suède] ; Kjell Grankvist [Suède]Interaction between cytostatics and nutrients
003273 (1987) Subject index—volume 82
003554 (1984) Toxicology author index volume 33 (1984)
003793 (1981) Richard D. Granstein [États-Unis] ; Arthur J. Sober [États-Unis]Drug- and heavy metal-induced hyperpigmentation

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Doxorubicin" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Doxorubicin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Doxorubicin
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021